> Detailanzeige

Auzanneau, Marie [Verfasser:in]; Eckert, Alexander J. [Verfasser:in]; Meyhöfer, Sebastian M. [Verfasser:in]; Heni, Martin [Verfasser:in]; Gillessen, Anton [Verfasser:in]; Schwettmann, Lars [Verfasser:in]; Jehle, Peter M. [Verfasser:in]; Hummel, Michael [Verfasser:in]; Holl, Reinhard W. [Verfasser:in]

Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany
  • Beteiligte: Auzanneau, Marie [Verfasser:in]; Eckert, Alexander J. [Verfasser:in]; Meyhöfer, Sebastian M. [Verfasser:in]; Heni, Martin [Verfasser:in]; Gillessen, Anton [Verfasser:in]; Schwettmann, Lars [Verfasser:in]; Jehle, Peter M. [Verfasser:in]; Hummel, Michael [Verfasser:in]; Holl, Reinhard W. [Verfasser:in]
  • Erschienen: Frontiers Research Foundation, 2023-08-01
  • Sprache: Ohne Angabe
  • DOI: https://doi.org/10.3389/fendo.2023.1191138
  • ISSN: 1664-2392
  • Schlagwörter: Medicine and health
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: Introduction: Diabetes technology improves glycemic control and quality of life for many people with type 1 diabetes (T1D). However, inequalities in access to diabetes technology exist in many countries. In Germany, disparities in technology use have been described in pediatric T1D, but no data for adults are available so far. We therefore aimed to analyze whether demographic factors and area deprivation are associated with technology use in a representative population of adults with T1D. Materials and methods: In adults with T1D from the German prospective diabetes follow-up registry (DPV), we analyzed the use of continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM), and sensor augmented pump therapy (SAP, with and without automated insulin delivery) in 2019-2021 by age group, gender, migration background, and area deprivation using multiple adjusted regression models. Area deprivation, defined as a relative lack of area-based resources, was measured by quintiles of the German index of Multiple Deprivation (GIMD 2015, from Q1, least deprived, to Q5, most deprived districts). Results: Among 13,351 adults with T1D, the use of technology decreased significantly with older age: CSII use fell from 56.1% in the 18−<25-year age group to 3.1% in the ≥80-year age group, CGM use from 75.3% to 28.2%, and SAP use from 45.1% to 1.5% (all p for trend <0.001). The use of technology was also significantly higher in women than in men (CSII: 39.2% vs. 27.6%; CGM: 61.9% vs. 58.0%; SAP: 28.7% vs. 19.6%, all p <0.001), and in individuals without migration background than in those with migration background (CSII: 38.8% vs. 27.6%; CGM: 71.1% vs. 61.4%; SAP: 30.5% vs. 21.3%, all p <0.001). Associations with area deprivation were not linear: the use of each technology decreased only from Q2 to Q4. Discussion: Our real-world data provide evidence that higher age, male gender, and migration background are currently associated with lower use of diabetes technology in adults with T1D in Germany. ...